These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 14604448)

  • 1. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Miller AL; Rogers GR; Kennedy MA
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):339-46. PubMed ID: 14604448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan: large neutral amino acid ratio and serotonin transporter polymorphisms.
    Joyce PR; Porter RJ; Mulder RT; Luty SE; McKenzie JM; Miller AL; Kennedy MA
    Psychol Med; 2005 Apr; 35(4):511-7. PubMed ID: 15856721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
    Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.
    Perlis RH; Mischoulon D; Smoller JW; Wan YJ; Lamon-Fava S; Lin KM; Rosenbaum JF; Fava M
    Biol Psychiatry; 2003 Nov; 54(9):879-83. PubMed ID: 14573314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic, developmental and personality correlates of self-mutilation in depressed patients.
    Joyce PR; McKenzie JM; Mulder RT; Luty SE; Sullivan PF; Miller AL; Kennedy MA
    Aust N Z J Psychiatry; 2006 Mar; 40(3):225-9. PubMed ID: 16476149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression.
    Roberts RL; Joyce PR; Mulder RT; Begg EJ; Kennedy MA
    Pharmacogenomics J; 2002; 2(3):191-6. PubMed ID: 12082591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder.
    Gudayol-Ferré E; Herrera-Guzmán I; Camarena B; Cortés-Penagos C; Herrera-Abarca JE; Martínez-Medina P; Cruz D; Hernández S; Genis A; Carrillo-Guerrero MY; Avilés Reyes R; Guàrdia-Olmos J
    J Affect Disord; 2010 Dec; 127(1-3):343-51. PubMed ID: 20584552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.
    Akhondzadeh S; Faraji H; Sadeghi M; Afkham K; Fakhrzadeh H; Kamalipour A
    J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Rae AM
    Acta Psychiatr Scand; 2003 Jul; 108(1):20-3. PubMed ID: 12807373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.
    Hong CJ; Chen TJ; Yu YW; Tsai SJ
    Pharmacogenomics J; 2006; 6(1):27-33. PubMed ID: 16302021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
    Roberts RL; Mulder RT; Joyce PR; Luty SE; Kennedy MA
    Hum Psychopharmacol; 2004 Jan; 19(1):17-23. PubMed ID: 14716707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial platelet serotonin (5-HT) transport kinetics predict nortriptyline treatment outcome.
    Rausch JL; Moeller FG; Johnson ME
    J Clin Psychopharmacol; 2003 Apr; 23(2):138-44. PubMed ID: 12640215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orosomucoid influences the response to antidepressants in major depressive disorder.
    Harley J; Roberts R; Joyce P; Mulder R; Luty S; Frampton C; Kennedy M
    J Psychopharmacol; 2010 Apr; 24(4):531-5. PubMed ID: 19395425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Sullivan PF; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):376-83. PubMed ID: 12060187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.